The subunit structure of human macrophage migration inhibitory factor (MIF) has been studied by preliminary X-ray analysis of wild-type and selenomethionine-MIF and dynamic light scattering. Crystal form I of MIF belongs to space group Pl x 2{l x and is grown from 2 M ammonium sulfate at pH 8.5. A native data set has been collected to 2.4 A resolution. Self-rotation studies and V m values indicate that three molecules per asymmetric unit are present A data set to 2.8 A resolution has been collected for crystal form II, which belongs to space group P3{21 or P3 2 2l and grows from 2 M ammonium sulfate, 2% polyethylene glycol (average molecular mass 400), 0.1 M HEPES, pH 7.5. Three, four, five or six monomers in the asymmetric unit are consistent with V m values for this crystal form. Analysis of crystal form II containing selenomethionine-MIF indicates nine selenium sites are present per asymmetric unit Dynamic light scattering of MIF suggests that the major form of the protein in solution is a trimer. The results of these studies are in contrast to previous reports indicating that MIF is a monomer or dimer. The subunit arrangement of MIF is similar to that of tumor necrosis factor and suggests that signal transduction might require trimerization of receptor subunits.
Introduction
Macrophage migration inhibitory factor (MIF) was originally identified as a lymphocyte-derived protein that inhibits monocyte migration and was implicated in delayed-type hypersensitivity (Bloom and Bennett, 1966) . Subsequently, the pituitary (Bemhagen et al, 1993) and macrophages (Calandra et al, 1994) have been found to be the source of most MIF in the serum. MIF is also produced in the brain and the developing eye (Wistow et al, 1993; Galat et al, 1994) . The precise physiological role of MIF is unknown, but most of its in vitro activities are associated with immune system function. MIF induces the production and release of tumor necrosis factor-ot and nitric oxide in macrophages (Bernhagen et al, 1994; Calandra et al, 1994) . MIF secretion is induced by glucocorticoids. In turn, MIF counter-regulates the actions of glucocorticoids and serves to inhibit the protective effects of glucocorticoids against lethal endotoxemia (Calandra et al, 1995) . In vivo studies also support a critical role for MIF in sepsis: co-injection of LPS and MIF in mice potentiates lethality; injection of anti-MTF antibody confers significant protection against LPS-induced death (Bemhagen et al, 1993) .
In addition to immune system activities, MIF is also reported to have glutathione S-transferase activity, potentially linking the host's chemical and immunological defense systems (Blocki et al, 1992) . Whether MIF is structurally related to other glutathione S-transferases (GST) is controversial. Three observations indicate that these proteins may be related. (1) MIF and other glutathione S-transferases share about 28% sequence identity at the amino terminus (seven out of 25 residues) (Blocki et al., 1992) . (2) Glutathione S-transferases have a conserved hydroxyl-containing residue (serine for 0-class GST and tyrosine for a-, n-and (X-class GSTs) at the active site which is involved in the deprotonation of the glutathione thiol group (Liu et al, 1992) . MIF also has a hydroxyl-containing residue (threonine) at the equivalent position (Blocki et al, 1993) . (3) Antibodies to MTF are reported to show cross-reactivity with 0-class GST (Blocki et al, 1993) . Based on these observations, MIF is proposed to be related to certain classes of glutathione S-transferases (Blocki et al, 1992 (Blocki et al, , 1993 . The contention that MIF is related to any of the glutathione S-transferases has been challenged based on the weak sequence similarity along the entire length of the proteins (Pearson, 1994) . Furthermore, the MTF polypeptide is only half the size of GST. Circular dichroism and NMR experiments as well as secondary structure predictions based on the primary sequence indicate MTF has a low helix content (Bernhagen et al, 1994; Nishihira et al, 1995) . In contrast, the three-dimensional structures of a number of glutathione S-transferases indicate they have a high helix content Reinemer et al, 1991 Reinemer et al, , 1992 .
The subunit structure of MIF has been the subject of interest and may be important for understanding the mechanism of receptor-induced signal transduction. Gel filtration experiments indicate that MIF exists as a monomer (Blocki et al, 1992; Galat et al, 1994) or dimer (Zeng et al, 1993) . Analytical ultracentrifugation of rat liver MTF indicates that the protein is a dimer (Nishihira et al, 1995) . In order to clarify these issues, we have embarked on the structural characterization of human MIF and present evidence that the protein is a trimer in two crystal forms and in solution.
Materials and methods

Expression and purification of recombinant MIF
The cloning of human MTF into the IPTG-inducible expression plasmid pETllb has already been described (Bemhagen et al, 1994) . BL21(DE3) cells grown to an ODeoo of 0.5-1.0 were induced by addition of IFTG to a final concentration of 0.4 mM. After a 4 h growth, the cells were harvested and resuspended in 20 mM NaCl, 20 mM Tris, pH 7.5, at 4% of the original volume of the growth media. Cells were lysed using a French Press and centrifuged at 100 000 g for 30 min to remove cell debris. The supernatant was sequentially applied over 5/10 Mono Q (Pharmacia) anion-exchange and Mono S (Pharmacia) cation-exchange columns. Under these conditions MIF is not retained by either column, but retention of bacterial proteins on either column results in ~95% purification of MIF. Further purification for crystallization is unnecessary but gel filtration chromatography using a Superdex 200 column (Pharmacia) removes many of the remaining contaminants ( Figure 1 ).
Expression and purification of selenornethionine-MIF
The methionine auxotroph B834(DE3) was used for replacement of methionine residues in MIF with selenomethionine. A clone of B834(DE3) transformed with the pETllb-MIF plasmid was grown to saturation in media containing M9 salts (Sambrook et al., 1989) , 2 raM MgSO 4 ,1.2% dextrose, 0.1 mM CaCl2, 0.1% casamino acids, 1 mg/ml thiamine and 100 (ig/ml ampicillin. To initiate selenomethionine incorporation, cells were diluted into media in which the 0.1% casamino acids were replaced with 40 |i.g/ml of each amino acid (excluding methionine and cysteine) and 40 (ig/ml of selenomethionine. The cells were induced with 0.4 mM IPTG at an OD^ of 0.85 and allowed to grow for another 15 h. Selenomethionine-MIF ([Se-Met]-M1F) was purified as above. Amino acid analysis and mass spectrometry Amino acid analysis was performed after hydrolysis of 3 (ig of MIF in 6 M HC1 with 0.2% phenol at 115 °C in vacuumsealed tubes for 16 h. Amino acids were analyzed on a Beckman (Model 7300) automatic amino acid analyzer. N-Terminal amino acid sequences were determined by automated Edman degradation using an Applied Biosystems Model 470A gas-phase sequencer. For mass spectrometry, MIF and [Se-Met]-MIF were further purified by HPLC using a Vydec protein C4 column and eluted with a gradient of 30-80% acetonitrile in 0.1% trifluoroacetic acid. Samples were diluted into 2-propanol and water (1:1, v/v) with 0.1% formic acid and analyzed on a VG Quattro (Fisons Instruments) triple quadropole mass spectrometer equipped with an electrospray ion source. The mass spectra of MIF and [Se-Met]-MIF are shown in Figure 2 .
Crystallization
The sparse matrix crystallization approach (Jancarik and Kim, 1991) was carried out using the hanging drop method at room temperature with up to 2 \i\ of protein solution and an equal volume of reservoir solution. Crystals were observed within 3 632 days under two conditions: (1)2% polyethylene glycol (PEG) 400, 2.0 M ammonium sulfate, 0.1 M HEPES, pH 7.5, and (2) 2.0 M ammonium sulfate, 0.1 M Tris, pH 8.5. Crystals from either condition grow to their final size by two weeks. The largest crystals have dimensions of 0.8X0.6X0.2 mm. For data collection and characterization, each crystal was mounted in a quartz capillary tube (Charles Supper Co.) with mother liquor on each side of the crystal to prevent drying, and the capillary tube was sealed with wax. X-ray data collection A full data set was collected from crystals grown in the presence or absence of 2% PEG 400. Data were collected as 0.25° oscillation images on a Siemens X-1000 area detector system using Cu Ka X-rays generated from a Rigaku RU200 rotating anode generator operated at 60 mA and 50 kV with focusing mirrors. These frames were processed with a version of XDS that allows unit cell dimensions and space groups to be determined (Kabsch, 1993) . Dynamic light scattering A solution of MEF at 5 mg/ml in 20 mM NaCl and 20 mM Tris, pH 7.5, was filtered through a 0.02 (im porosity filter prior to injecting the sample into a DynaPro-801 light scattering instrument (Protein Solutions Inc., Charlottesville, VA). Repeated measurements of the diffusion coefficient of the protein sample indicate MIF is monodisperse with a hydrodynamic radius of 26-28 A (Table I) .
Results
Expression and purification of recombinant and [Se-Met]-modified MIF
MIF has been expressed in the pET system (Studier et al., 1990) and constitutes about 40% of the supernatant from Escherichia coli. The protein is purified to 95% homogeneity using two ion-exchange chromatographic steps. The molecular weight of the polypeptide based on SDS-PAGE is -12.5 kDa (Figure 1 ). Mass spectrometry indicates that a single polypeptide of MIF has a molecular weight of 12 347.29 ± 4.05 Da (Figure 2 ). The incorporation of selenomethionine in MIF requires growth in minimal media and results in a lower yield. The molecular weight of [Se-Met]-MIF by mass spectrometry is 12 484.88 ± 1.47, indicating that selenium atoms are incorporated in place of sulfur for three of the four methionine residues of MIF. Amino acid analysis and sequencing indicate that the N-terminal methionine is not present after purification (data not shown).
X-ray analysis
Two crystals grown in the absence of PEG 400 were used to collect 2.4 A data with an Rm^e ( on intensities) of 4.2% for 21 792 measurements of 12 631 unique reflections (73% complete to 2.4 A resolution). In general, crystals grown in the absence of PEG 400 belong to space group P1{1{1\ with unit cell dimensions a = 68.79 A, b = 68.44 A, c = 87.24 A. Using a molecular mass of 12.5 kDa, V m values of 8.5, 4.2, 2.8 and 2.1 A 3 /Da were calculated for one, two, three and four monomers per asymmetric unit, respectively. Only the V m values for three and four monomers in the asymmetric unit are typical of protein crystals (Matthews, 1968) . A self-rotation analysis of the X-ray data reveals the presence of a threefold non-crystallographic axis, indicating that three monomers are present in the asymmetric unit (Figure 3) .
Crystals grown in the presence of 2% PEG 400 usually The selfrotation function is calculated using the program MERLOT (Fitzgerald, 1988) with data from 10 to 4 A having intensities greater than 2a and a Patterson cutoff radius of 23.0 A. The map is contoured starting at 0.5a with 0.5a increments, a being the root mean square value of the rotation function.
presence of 2% PEG 400 and belong to the trigonal crystal form. These crystals are usually smaller (0.4X0.3X0.3 mm) than wild-type crystals but diffract to higher resolution. A full data set to 2.6 A resolution with an Emerge of 5.1% was collected. The mean isomorphous difference of these data was 11%. Difference Patterson maps were calculated using the PHASIT package (W.Furey) but could not be used to solve the positions of the selenium atoms. Direct methods using SHELXS (Sheldrick, 1990) with data from 10 to 5 A revealed nine sites having peak heights that gradually decreased to 68% of the maximum. The peak height of the tenth potential site decreased dramatically to 43% of the maximum, suggesting that nine selenium atoms are present per asymmetric unit These sites were refined and are shown in Table n . The validity of the positions was confirmed by checking the predicted selfand cross-vectors against the Patterson map. Difference maps calculated with single isomorphous replacement (SIR) were also utilized. Sets of two or three selenium sites were deleted prior to' calculating SIR phases and difference maps. Peaks always appeared corresponding to the positions of the deleted atoms for all nine sites. Based on amino acid analysis showing that three methionine residues are present in a single polypeptide chain of purified MIF, these data indicate that three monomers are present per asymmetric unit of the trigonal crystal form. 
Dynamic light scattering
In light of the presence of three monomers in the asymmetric unit of both space groups we sought to determine the subunit structure of MIF in solution. Based on the standard sizeweight relationship typical of globular proteins, the hydrodynamic radius indicates that the size of MIF is 30-40 kDa, consistent with a trimeric structure for MIF (Table I) .
Discussion
The oligomeric structure of cytokines can provide clues as to the mechanism of receptor activation at the cell surface. It is important to note, however, that the functional form of a cytokine may not correspond to the experimentally observed form, as structure determinations are done at higher concentrations than those required for biological activity. It can be argued that at these high concentrations, mass action is responsible for subunit-subunit interactions which would normally not occur at biologically effective concentrations. Notwithstanding this caution, tumor necrosis factor (TNF) and interferon-y (IFN-y) are two prime examples which illustrate that the oligomeric state of the uncomplexed protein is directly related to the mechanism of receptor activation. Tumor necrosis factor was found to be a trimer in solution and in the crystal (Smith and Baglioni, 1987) . The determination of the threedimensional structure of the TNF-TNF receptor complex clearly demonstrates that the TNF trimer induces trirnerization of its receptor (Banner et al, 1993) . Likewise, uncomplexed interferon-y exists in solution and in the crystal as a dimer (Samudi et al, 1991; Grzesiek et al, 1992) . The structure of the IFN-y-IFN receptor complex shows that the IFN-y dimer leads to receptor dimerization and activation at the cell surface (Walter et al, 1995) . Previous studies using either gel filtration chromatography or equilibrium sedimentation experiments of rat, bovine, and human MIF demonstrate that the protein exists as a monomer or a dimer (Blocki et al, 1992; Zeng et al, 1993; Galat et al, 1994; Nishihira et al, 1995) . In a preliminary crystallization study, MIF is assumed to form a dimer and it is concluded that two or three dimers are present in the trigonal crystal form and two dimers are present in the orthorhombic crystal form (Suzuki et al, 1994) . Our analysis based on dynamic light scattering, self-rotation studies of the orthorhombic crystal form and determination of selenium sites in the trigonal crystal of [Se-Met]-MIF indicates that human MIF exists as a trimer. It is possible that the high protein concentrations involved in crystallization and dynamic light scattering relative to the reported gel filtration experiments may provide an explanation for the different conclusions. However, it is difficult to rationalize the discrepancy between our conclusions with those of the analytical ultracentrifugation study (Nishihira et al, 1995) . The determination of the solution and crystal structure of MIF should resolve questions regarding its subunit arrangement and address structure-function relationships of the protein considered to be the first lymphokine ever characterized. The determination of the crystal structure by isomorphous replacement is in progress. The presence of a non-crystallographic threefold axis will allow molecular averaging to be used for structure determination.
